These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34358298)

  • 1. Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
    Pol T; Hijazi Z; Lindbäck J; Oldgren J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Yusuf S; Siegbahn A; Wallentin L
    Cardiovasc Res; 2022 Jul; 118(9):2112-2123. PubMed ID: 34358298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
    Hijazi Z; Wallentin L; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Pol T; Yusuf S; Oldgren J; Siegbahn A
    J Am Heart Assoc; 2020 Dec; 9(24):e018984. PubMed ID: 33292046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
    Sharma A; Hijazi Z; Andersson U; Al-Khatib SM; Lopes RD; Alexander JH; Held C; Hylek EM; Leonardi S; Hanna M; Ezekowitz JA; Siegbahn A; Granger CB; Wallentin L
    Circulation; 2018 Oct; 138(16):1666-1676. PubMed ID: 29871978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
    J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
    Siegbahn A; Lindbäck J; Hijazi Z; Åberg M; Alexander JH; Eikelboom JW; Lopes RD; Pol T; Oldgren J; Granger CB; Yusuf S; Wallentin L
    J Thromb Haemost; 2021 Nov; 19(11):2726-2737. PubMed ID: 34390530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the  RE - LY Trial.
    Hijazi Z; Verdecchia P; Oldgren J; Andersson U; Reboldi G; Di Pasquale G; Mazzotta G; Angeli F; Eikelboom JW; Ezekowitz MD; Connolly SJ; Yusuf S; Wallentin L
    J Am Heart Assoc; 2019 Jan; 8(2):e010107. PubMed ID: 30651032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
    Wallentin L; Eriksson N; Olszowka M; Grammer TB; Hagström E; Held C; Kleber ME; Koenig W; März W; Stewart RAH; White HD; Åberg M; Siegbahn A
    PLoS Med; 2021 Jan; 18(1):e1003513. PubMed ID: 33439866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Wallentin L; Hijazi Z; Andersson U; Alexander JH; De Caterina R; Hanna M; Horowitz JD; Hylek EM; Lopes RD; Asberg S; Granger CB; Siegbahn A;
    Circulation; 2014 Nov; 130(21):1847-58. PubMed ID: 25294786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.
    Hijazi Z; Aulin J; Andersson U; Alexander JH; Gersh B; Granger CB; Hanna M; Horowitz J; Hylek EM; Lopes RD; Siegbahn A; Wallentin L;
    Heart; 2016 Apr; 102(7):508-17. PubMed ID: 26839066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
    Oldgren J; Hijazi Z; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Granger CB; Hylek EM; Lopes RD; Siegbahn A; Yusuf S; Wallentin L;
    Circulation; 2016 Nov; 134(22):1697-1707. PubMed ID: 27569438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.
    Pol T; Hijazi Z; Lindbäck J; Alexander JH; Bahit MC; De Caterina R; Eikelboom JW; Ezekowitz MD; Gersh BJ; Granger CB; Hylek EM; Lopes R; Siegbahn A; Wallentin L
    Open Heart; 2021 Mar; 8(1):. PubMed ID: 33741689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model.
    Aulin J; Hijazi Z; Lindbäck J; Alexander JH; Gersh BJ; Granger CB; Hanna M; Horowitz J; Lopes RD; McMurray JJV; Oldgren J; Siegbahn A; Wallentin L;
    Am Heart J; 2022 Sep; 251():13-24. PubMed ID: 35569564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
    Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
    Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
    Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R
    BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score.
    Hijazi Z; Oldgren J; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Held C; Hylek EM; Lopes RD; Yusuf S; Granger CB; Siegbahn A; Wallentin L;
    Eur Heart J; 2018 Feb; 39(6):477-485. PubMed ID: 29069359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy.
    Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Ezekowitz MD; Hohnloser SH; Reilly PA; Vinereanu D; Siegbahn A; Yusuf S; Wallentin L
    Circulation; 2012 Apr; 125(13):1605-16. PubMed ID: 22374183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial.
    Røsjø H; Hijazi Z; Omland T; Westerbergh J; Lyngbakken MN; Alexander JH; Gersh BJ; Granger CB; Hylek EM; Lopes RD; Siegbahn A; Wallentin L
    J Intern Med; 2020 Aug; 288(2):248-259. PubMed ID: 32350915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
    Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
    JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
    Oyama K; Giugliano RP; Berg DD; Ruff CT; Jarolim P; Tang M; Murphy SA; Lanz HJ; Grosso MA; Antman EM; Braunwald E; Morrow DA
    Eur Heart J; 2021 May; 42(17):1698-1706. PubMed ID: 33760027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.